Business Standard

Maiden Pharma cough syrup row: Gambian Parliament seeks legal action

WHO, however, said samples tested in Ghana and Switzerland were found to be contaminated

cough syrup, medicine, cold
Premium

File photo of cough syrup | Photo: Shutterstock

Sohini Das Mumbai
The issue of cough syrups manufactured by Maiden Pharmaceuticals allegedly leading to deaths of 70 children in Gambia was raked up again in the African nation.

According to BBC, a parliamentary committee in Gambia has recommended prosecution of “an Indian manufacturer of cough syrups suspected of causing deaths of at least 70 children in the West African country”.

The Union Ministry of Health could not be reached for comment on the matter. Maiden Pharma, too, could not be reached for a comment.

According to the report, after weeks of investigation, the Gambian parliamentary committee decided that authorities should take tough

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in